NRIX
Nurix Therapeutics Inc
Price:  
13.59 
USD
Volume:  
680,828.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NRIX WACC - Weighted Average Cost of Capital

The WACC of Nurix Therapeutics Inc (NRIX) is 7.1%.

The Cost of Equity of Nurix Therapeutics Inc (NRIX) is 9.20%.
The Cost of Debt of Nurix Therapeutics Inc (NRIX) is 5.00%.

Range Selected
Cost of equity 8.10% - 10.30% 9.20%
Tax rate 0.10% - 0.10% 0.10%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.5% - 7.7% 7.1%
WACC

NRIX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.91 0.98
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.10% 10.30%
Tax rate 0.10% 0.10%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.5% 7.7%
Selected WACC 7.1%